Dossier
mRNA flu shot
Coverage of mRNA flu shot in the Nexus archive.
- STAT+: Is there a pharma mega-merger in the making?
The article discusses the FDA's upcoming decision on Moderna's mRNA flu shot, a renewed debate over 340B rebates, and legal challenges regarding Lilly's insulin pricing. It highlights key developments in the biotech and pharmaceutical sectors.
- FDA Staff Weighs In on Potential First mRNA Flu Shot
FDA reviewers have not raised serious efficacy or safety concerns about Moderna's mRNA flu vaccine candidate ahead of an advisory committee meeting. The vaccine could become the first mRNA-based flu shot approved by the FDA.